Advances in Clinical and Experimental Medicine

Advances in Clinical and Experimental Medicine Advances in Clinical and Experimental Medicine (JCR impact factor = 2.1) is a peer-reviewed open a

Publish in Advances in Clinical and Experimental Medicine!WHY?– We have a broad scope and publish papers from all fields...
17/02/2025

Publish in Advances in Clinical and Experimental Medicine!

WHY?
– We have a broad scope and publish papers from all fields of medicine and related sciences;
– Our Impact Factor is 2.1 and steadily rising [see below];
– Our Scopus CiteScore is 3.7 and also steadily rising;
– We publish papers ahead of print [with active DOI] as soon as they are ready – no unnecessary waiting;
– We are indexed in all important databases;
– We offer professional linguistic editing and DTP;
– If you become our reviewer, article processing charge can be waivered.

HOW?
Create an account here:
https://www.editorialsystem.com/acem/preRegister/?email=
Check our instructions for authors here:
https://advances.umw.edu.pl/en/instructions-for-authors/
and submit your paper!

EDITORIALS
We invite experts to submit an editorial to our journal. Editorials published in our journal are meant to promote current and crucial directions of research in experimental and clinical medicine. Such article is published free of charge.
https://advances.umw.edu.pl/source/Flyer_ACEM_popr_2025-editorial.pdf

CALLS FOR SUBMISSION
Current calls for submissions in ACEM are listed below. Please share them with the members of your professional networks.
https://advances.umw.edu.pl/en/calls-for-submissions/

OUR IMPACT FACTOR
There has been a rise in the impact factor value for ACEM since 2018. A constant rise in this value shows that the position of ACEM among medical journals is gradually increasing. The current value of impact factor is 2.1. The approximate value of impact factor 2022 is 2.020.

CHECKLISTS – WHY and HOW?Many journals expect authors to choose a proper checklist when submitting a paper, fill it in a...
16/02/2025

CHECKLISTS – WHY and HOW?

Many journals expect authors to choose a proper checklist when submitting a paper, fill it in and submit together with the manuscript. If you experience problems when choosing such checklist or just want to know more – read this editorial prepare by our editors.

https://advances.umw.edu.pl/en/article/2022/31/10/1065/

Types of articles in Advances in Clinical and Experimental Medicine in 2021 and 2022: Editors’ perspectiveThe present ed...
15/02/2025

Types of articles in Advances in Clinical and Experimental Medicine in 2021 and 2022: Editors’ perspective

The present editorial summarizes the last 2 calendar years of Advances in Clinical and Experimental Medicine (ACEM) publication (2021 and 2022). The specific aims were: 1) To clarify the classification of papers published in ACEM; 2) To present motivations behind choosing this classification; 3) To show how this classification is reflected in citations. Six categories of papers published in ACEM are presented: editorials, meta-analyses, reviews (including systematic reviews), multicenter studies, research-in-progress studies, and research letters; lack of clear definitions for editorials, research letters and research-in-progress studies is discussed. Thematic fields covered by all categories in 2021 and 2022 are presented and differences in this regard between 2021 and 2022 are highlighted. Reasons for not publishing case reports (CRs) are discussed, with some of the debate on this issue in medical literature summarized. The article type classification used in ACEM in only one of many possible solutions and may be modified in the future – it should be both clear for the authors and allow for orientation in the journal’s content. The motivation for choosing the employed categories stem both from their position on the accepted levels of evidence in evidence-based medicine (EBM) and their potential to be cited.

https://advances.umw.edu.pl/en/ahead-of-print/176003/

New call for submissions Innovations in Therapeutic Interventions: Advancing Clinical and Experimental MedicineHandling ...
14/02/2025

New call for submissions

Innovations in Therapeutic Interventions: Advancing Clinical and Experimental Medicine

Handling Editors
Dr. Masaru Tanaka (ELKH-SZTE Neuroscience Research Group, Eötvös Loránd Research Network, University of Szeged (ELKH-SZTE), Hungary)
Dr. Simone Battaglia (Center for Studies and Research in Cognitive Neuroscience, Department of Psychology, University of Bologna, Italy
Dr. Francesco Di Gregorio (AUSL Bologna; Department of Psychology, University of Bologna, Italy)
Prof. Izabella Uchmanowicz (Wroclaw Medical University, Poland)
Prof. Donata Kurpas (Wroclaw Medical University, Poland)

Advances in Clinical and Experimental Medicine (Adv Clin Exp Med; IF 2.1, Scopus CiteScore 3.4) cordially invites you to contribute your valuable research to our esteemed journal. We are dedicated to promoting groundbreaking advancements in clinical and experimental medicine, focusing on emerging therapeutic strategies. We aim to enhance our impact factor and facilitate collaborations that drive progress in medicine.

We welcome reviews as well as original research articles and research letters in various clinical and experimental medicine areas. We encourage submissions on the following topics:

Precision Medicine and Personalized Therapies: Explore novel approaches in tailoring medical treatments based on an individual's genetic makeup, environmental factors, and disease characteristics. Highlight the potential of precision medicine in improving patient outcomes and overcoming treatment challenges. This topic includes but is not limited to:

a) Immunotherapy and Immunomodulation: Investigate the role of immunotherapy and immunomodulation in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. Focus on cutting-edge techniques, therapeutic targets and potential synergies with other treatment modalities.
b) Gene and Cell Therapies: Present innovative research on gene and cell-based therapies, such as stem cell transplantation, gene editing and regenerative medicine. Explore their applications across different diseases and discuss their clinical implications and prospects.

The paper can also encompass:
Artificial Intelligence and Big Data Analytics in Medicine: Examine the integration of artificial intelligence (AI) and big data analytics in medical research, diagnostics, treatment optimization, and patient care. Highlight the potential of AI algorithms, machine learning and data-driven approaches in revolutionizing healthcare practices.
Digital Health Technologies and Wearables: Discuss the advancements in digital health technologies (including telemedicine), wearable devices and remote monitoring systems. Explore their impact on healthcare delivery, patient engagement, disease management, and prevention strategies.

All papers should focus on:
Translational Research and Bench-to-Bedside Innovations: Showcase translational research efforts that bridge the gap between laboratory discoveries and clinical applications. Present successful examples of bench-to-bedside innovations that have improved patient care and outcomes.

Keywords
therapeutic interventions; personalized therapies; immunotherapy; immunomodulation; gene and cell therapies; artificial intelligence; Big Data analytics; digital health technologies

By submitting your research to Adv Clin Exp Med, you will become an integral part of a dynamic and vibrant community of dedicated researchers committed to advancing the fields of clinical and experimental medicine. By undergoing our rigorous peer-review process, you can be assured that only high-quality and impactful studies are published, enhancing your professional reputation and contributing to advancing medical knowledge.

We look forward to receiving your submissions and collaborating to make a lasting impact on the field of clinical and experimental medicine.

Submission process
As a first step, we ask for submissions of an Expression of Interest with an Abstract of original papers outlining the themes above to Adv Clin Exp Med Managing Editor Marek Misiak: [email protected]
The Editor-in-Chief will review all submissions and select those invited to submit a full paper. The submission process will follow the regular Adv Clin Exp Med online process. All manuscripts will be sent to at least two independent reviewers.

Dates and fees
Submission of Expression of Interest until April 30, 2024, to the ACEM Managing Editor: [email protected];

Invitation to submit the full paper by May 31, 2024;

Submission of full paper by September 30, 2024.

If accepted, Authors will be required to pay a fee to cover publication costs (https://advances.umw.edu.pl/en/article-processing-charges/). For selected Authors (outstanding experts), reducing or even cancelling the publication fee is possible.

We look forward to a wide variety and genuinely global collection of papers and experiences to push worldwide science to the next level!

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

The Author of our current Editorial„Investigating gender dynamics in forensic toxicology: The role of masculinity and fe...
13/02/2025

The Author of our current Editorial

„Investigating gender dynamics in forensic toxicology: The role of masculinity and femininity in alcohol and drug abuse

https://advances.umw.edu.pl/en/article/2025/34/1/5/

Arianna GIORGETTI
Department of Medical and Surgical Sciences, Unit of Legal Medicine, University of Bologna, Italy
[email protected]

Education and main Academic roles
I earned my medical degree cm laude and with the highest honours from the Politecnica University of Marche in 2015, completing a short internship of a few months at the University of Hertfordshire, School of Life and Medical Sciences (Hatfield, Herts,UK). I completed in 2020 my postgraduate specialization in Legal Medicine at the University of Modena and Reggio Emilia, after attending two years at the University of Padua, and one year at the University of Freiburg, Gerrmany, at the Unit of Legal Medicine and Forensic Toxicology. Last year I obtained a PhD in General Medical and Services Sciences, with a curriculum in Bio-medico-legal sciences, at the University of Bologna, while being appointed since 2021 as a Junior Assistant Professor of Legal Medicine in the Department of Medical and Surgical Sciences at the University of Bologna.

Memberships and Appointments
Recipient of an international Scientific Awards in Forensic Toxicology by the Society of Hair Testing and of several national Scientific Awards in Forensic Pathology. Active Reviewer of several peer-reviewed journals, Review and Guest Associated Editor of scientific journals all provided of impact factor, in the fields of Addictive disorders, Psychopharmacology, Environmental and Clinical Toxicology. Member of the American Academy of Forensic Science (AAFS) Section Toxicology, The International Association of Forensic Toxicologists (TIAFT), the Italian Group of Forensic Toxicology (G.T.F.I.)

Main Research Topics and Patents
I am interested in a wide range of research topics, including forensic and clinical toxicology, with a particular focus on NPS and biomarker of synthetic cannabinoids, environmental toxicology, forensic pathology, clinical forensic medicine and legal medicine, medical malpractice, forensic radiology, and applied artificial intelligence as well as telemedicine. I have written over eighty-five peer-reviewed papers, edited several treatises, and contributed to chapters in internationally recognized books. I am member of the unit of a nationally funded project and Principal Investigator of another funded project on environmental toxicology.

Ahead of printOtolaryngological manifestations in patients with obstructive sleep apnea and continuous positive airway p...
13/02/2025

Ahead of print

Otolaryngological manifestations in patients with obstructive sleep apnea and continuous positive airway pressure users: A systematic review

Sleep disorders have emerged as a significant public health issue, adversely affecting quality of life and precipitating severe complications. The association between obstructive sleep apnea syndrome (OSAS) and otolaryngological manifestations appears to be underrecognized. This study posits that manifestations in the ear, nose and throat (ENT) among patients with OSAS and users of continuous positive airway pressure (CPAP) therapy are relatively common. Utilizing the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement, this systematic review, registered at PROSPERO (No. CRD42023452473), involved a comprehensive search of the MEDLINE databases. We included studies published in English from 1979 to March 2021 that explored the linkages between OSAS, CPAP and otolaryngological manifestations. A total of 29 articles were reviewed, with findings indicating 12 studies on ear dysfunctions, 11 on nose dysfunctions and 6 on pharynx dysfunctions. Reported symptoms included hearing dysfunction, vestibular function disorders, cerebrospinal fluid leak, Eustachian tube (ET) dysfunction, rhinosinusitis, olfaction and taste disorders, dysphagia, dry mouth, and gastroesophageal reflux. The etiology of these ailments varies, yet an understanding of these symptoms can improve the diagnosis to confirm or rule out OSAS. Early identification of ENT symptoms related to OSAS may facilitate prompt diagnosis and mitigate serious complications.

https://advances.umw.edu.pl/en/ahead-of-print/195243/



Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

A Q&A with Professor Rafael Boscolo-Berto and Assistant Professor Arianna Giorgetti, authors of the editorial „Investiga...
12/02/2025

A Q&A with Professor Rafael Boscolo-Berto and Assistant Professor Arianna Giorgetti, authors of the editorial „Investigating gender dynamics in forensic toxicology: The role of masculinity and femininity in alcohol and drug abuse

https://advances.umw.edu.pl/en/article/2025/34/1/5/

What are the most common misconceptions about forensics and legal medicine among the general public?

There are several misconceptions about forensic medicine that are often reinforced by the mass media.
One of the most common misunderstandings is that forensic doctors primarily work on high-profile or extremely complex homicide cases, as frequently portrayed in fictional television programs. In reality, the work of a forensic doctor encompasses a wide range of cases, including routine incidents such as drug-related crimes, traffic accidents, and suspicious deaths.
Another misconception is about the speed at which results are produced by forensic laboratories for tests like genetic analysis or toxicology. The media often suggests that DNA tests or forensic toxicology results are available instantly; however, the truth is that forensic testing can take days, weeks, or even months, depending on the complexity of the case.
Lastly, many people believe that forensic medicine is an autonomous and isolated scientific field. In fact, it involves collaboration across various disciplines, including medical, biological, and criminalistic fields. This highlights that forensic medicine is a multifaceted practice rather than a single specialty.

Are new psychoactive substances (NPS) a challenge for forensic toxicology?

Since their first introduction and discovery, NPS have posed several challenges in forensic toxicology, and these issues are still unsolved despite the evolution of technologies and methods available. Just to mention a few of them, the number of NPS, more than 1000 compounds, together with their chemical diversity, makes it impossible to have a comprehensive detection of all compounds in a single analysis, requiring differentiated and target methods, a lot of time, generous amounts of biological material and a constant update. Forensic laboratories struggle to obtain reference standards that are often antieconomic and produced or received too late to provide realistic monitoring of the NPS market and consumption. Even when technologies and references are available, and this is not the case with most routine tests performed at the emergency department, the detection of NPS remains challenging due to low stability at environmental temperature, rapid elimination with limited detection time of most molecules in blood, and the unknown metabolic biomarkers in other matrices, e.g. in urines, that usually allow wider detection frames.

In the context of issues discussed in your editorial, is there a meaningful difference between s*x [biological] and gender [cultural], or is it a marginal problem regarding these topics?

In forensic toxicology, the distinction between biological s*x and gender, or social constructs, is crucial and both concepts should be considered deeply in order to reach an accurate interpretation of the cases under investigation.
Besides biological factors that may be better understood, it is important to note that societal expectations around masculinity and femininity could influence the exposure to drugs, the context in which substances are used, the patterns of consumption, the stigma associated with drug consumption and the request for healthcare by drug users. As the gender gap narrows in some societies, an increase in women experiencing drugs, including NPS, is expected, and this might be reflected in a migration toward certain groups of NPS, e.g. designer benzodiazepines, or in more challenging intoxication cases with co-use of antidepressants and/or sedatives.

Why is gender a factor potentially impacting decision-making in post-mortem forensic toxicology?

A critical step in post-mortem forensic toxicology is represented by the choice of toxicological analyses that could apply to the case, which is, in turn, influenced by the judicial authority requests and by the amount of biological material retrieved at postmortem examination. Gender can influence the contextual factors considered during investigations, e.g., with fear of social repercussions leading to lower report of drug use in women compared to men and to the absence of an important hint for toxicological analyses.
In this context, the misconception that NPS should be searched for only in the case of male deceased, or only when there is a well-described history of abuse of conventional drugs, could prevent the detection of these substances and contribute to the underreporting of NPS fatal cases.

The Author of our current Editorial„Investigating gender dynamics in forensic toxicology: The role of masculinity and fe...
11/02/2025

The Author of our current Editorial

„Investigating gender dynamics in forensic toxicology: The role of masculinity and femininity in alcohol and drug abuse

https://advances.umw.edu.pl/en/article/2025/34/1/5/

Rafael BOSCOLO BERTO
Department of Neuroscience, University of Padova, Italy
[email protected]

Education and main Academic roles
After earning my medical degree with the highest honours from the University of Padova in 2004, I completed my postgraduate specialization in Urology, graduating cm laude in 2010. In 2015, I pursued a second postgraduate specialization in Legal Medicine, achieving the top score. Additionally, I attended the "Cellular Energetics and Regulation - European Bioenergetics Course" in Konstanz, received a Fellowship from the European Board of Urology, and participated in several clinical courses organized by the European School of Urology.
Currently, I am an Associate Professor of Human Anatomy in the Department of Neurosciences at the University of Padova, Institute of Human Anatomy. I also serve as a member of the Academic Board for the Ph.D. Course in Clinical and Experimental Oncology and Immunology.

Memberships and Appointments
Recipient of three international/National Scientific Awards in Forensic Pathology, Medical Liability, and Human Anatomy. Executive Editorial Board member and senior reviewer of several scientific journals all provided of impact factor. Founding member, member of the Board of Directors, Treasurer of the Society of Clinical Forensic Anatomy (S.A.Cli.Fo.), other than a member of the Italian Society of Anatomy and Histology (S.I.A.I.), European Association of Clinical Anatomy (E.A.C.A.), American Association of Clinical Anatomists (A.A.C.A.), International Academy of Legal Medicine (I.A.L.M.), Forensic Anthropology Society of Europe (F.A.S.E.), and many other regional scientific associations. I have been a jury member for international awards in human anatomy and repeatedly served on international commissions for awarding European funds to research projects.

Main Research Topics and Patents
I am interested in a wide range of research topics, including clinical anatomy, forensic clinical anatomy, forensic pathology, legal medicine, medical malpractice, urology, and applied artificial intelligence. I have written over one hundred peer-reviewed papers, edited several treatises, and contributed to numerous chapters in internationally recognized books published by top publishing houses. Moreover, I am actively involved as an inventor in patent technology transfer on both national and international levels.

New category in our journal – Study Protocol articlesStudy Protocol articles provide a comprehensive overview of the des...
11/02/2025

New category in our journal – Study Protocol articles

Study Protocol articles provide a comprehensive overview of the design of prospective research, aiming to facilitate the dissemination of ongoing studies and enhance transparency in clinical and biomedical research. These articles outline the hypothesis, rationale, methodology, and ethical considerations of the study, serving as a valuable resource for researchers and clinicians.
We consider study protocols for proposed or ongoing prospective clinical research, provided that participant recruitment has not been completed at the time of submission. Protocols for retrospective studies, feasibility studies, or pilot studies are not eligible. Additionally, study protocols will not be considered if any articles reporting data from the study have already been published or are under review.

Submission Guidelines:

• Study Protocol articles undergo peer review.
• The manuscript should not exceed 3,500 words.
• A maximum of 10 figures and/or tables may be included.
• The paper should follow a 5-part structure: Highlights, Introduction, Methodology, Discussion, Conclusion.
• The abstract should not exceed 300 words and follow a 4-part structure: Introduction, Methodology, Discussion, Conclusion.
• Formal ethical approval of an appropriate ethics committee is mandatory.
• For clinical studies, registration in a public clinical trial registry is mandatory prior to manuscript submission.
• Authors are strongly encouraged to follow the SPIRIT guidelines (SPIRIT Statement).

This structured approach ensures that Study Protocol articles contribute meaningfully to the research community while maintaining rigorous academic and ethical standards.

https://advances.umw.edu.pl/en/instructions-for-authors/

From Bench to Bedside: Advances in Neuroinflammation and CNS Disorder ResearchAdvances in Clinical and Experimental Medi...
10/02/2025

From Bench to Bedside: Advances in Neuroinflammation and CNS Disorder Research

Advances in Clinical and Experimental Medicine
Adv Clin Exp Med

Call for submissions of an Expression of Interest for an Adv Clin Exp Med Special Collection on Neuroinflammation in CNS Disorders

The editors of this special collection invite submissions exploring the latest advances in clinical and experimental research on neuroinflammation in the central nervous system (CNS). Neuroinflammation is at the forefront of neuroscience, shaping our understanding of CNS disorders such as neurodegenerative disease, psychiatric disorders, and traumatic brain injuries. This collection aims to unite diverse perspectives, fostering insights into the complex cellular and molecular mechanisms driving neuroinflammatory processes. We encourage the submission of original research, meta-analyses, and comprehensive review articles that shed light on diagnostic, therapeutic, and mechanistic aspects of CNS inflammation.
We are particularly interested in manuscripts that explore the interplay between immune cells, neurons, and glia, with a focus on translational research. Contributions detailing innovative diagnostic approaches, therapeutic targets, or computational models are highly welcome. Join this effort to advance the boundaries of neuroinflammation research and contribute to groundbreaking findings that bridge laboratory and clinical neuroscience.

Topic and format
Advances in Clinical and Experimental Medicine is therefore seeking original papers for a Special Collection focused on the following themes:
• Neuroimmune Interactions in Health and Disease
• Cellular and Molecular Pathways of Neuroinflammation
• Neuroinflammation and Neurodegeneration: Cause or Consequence?
• Innovative Imaging and Biomarkers for CNS Inflammation
• Therapeutic Interventions Targeting Neuroinflammation
• Role of Microglia and Astrocytes in Neuroinflammatory Diseases

Submission process
As a first step, we ask for submissions of an Expression of Interest with an Abstract of original papers outlining the themes above to Adv Clin Exp Med Section Editor: [email protected].
The Section Editor jointly with the Editor-in-Chief will review all submissions and select those which will be invited to submit a full paper. The submission process will then follow the regular Adv Clin Exp Med online process. All manuscripts will be sent to at least two independent reviewers.

Dates and fees
• Submission of Expression of Interest until June 30, 2025, to [email protected];
• Invitation to submit full paper by August 31, 2025;
• Submission of full paper by December 31, 2025;
• If accepted, Authors will be required to pay a fee (https://advances.umw.edu.pl/en/article-processing-charges/) to cover publication costs;
• For selected Authors (outstanding experts), it is possible to reduce or even cancel the publication fee.

We eagerly anticipate a diverse and truly global collection of papers and insights, driving scientific discovery and innovation to new heights on the world stage!

You do the research – we take care of the textAuthors of papers accepted for publication may choose special services fro...
09/02/2025

You do the research – we take care of the text

Authors of papers accepted for publication may choose special services from our experienced editorial team. The offer concerns only paper submitted for publication after March 1, 2024.

There are additional fees for the following optional services (if ordered by the Authors of the manuscript accepted for publication):

200 EUR / 880 PLN for linguistic editing;
200 EUR / 880 PLN for technical editing.
Services offered
Linguistic editing ensures that the English language of your manuscript is of the academic standard required for publication in our journal. It comprises correcting grammar, punctuation and spelling errors, pointing to inconsistencies, as well as removing or reformulating awkward or ambiguous sentences, while keeping, where possible, your voice and choice of words. We also suggest discipline-specific terms. In the proof sent to you, all our comments and doubts are clearly marked, so that you could make the necessary corrections.

Technical editing ensures that the structure of your manuscript follows the Adv Clin Exp Med house style. We reformat references (both in the text and the whole reference list) and look for missing information in the reference section. We improve the overall presentation by revising titles/subtitles, font, spacing, text alignment, and paragraph structure. We also edit equations and tables, and produce publication-ready figures that clearly communicate your research to readers. Figure editing enhances your charts and graphs, as well as graphical abstracts; it comprises revising the text included, colors, shading, border, size, resolution, and file type.

You can choose either or both of the abovementioned optional services, or decline them. When submitting the manuscript to Adv Clin Exp Med via the Editorial System, you will be provided with special checkboxes to select if needed. Following the acceptance of your article for publication, you will be asked to pay the basic APC and the additional fees for the chosen editing services.

Please be informed that the articles finally published in Adv Clin Exp Med must comply with the high standards of the journal.

More information: Managing Editor [email protected]

NEW REQUIREMENTS CONCERNING FIGURES IN ADV CLIN EXP MEDWe implemented new requirements regarding figures – they stem fro...
08/02/2025

NEW REQUIREMENTS CONCERNING FIGURES IN ADV CLIN EXP MED

We implemented new requirements regarding figures – they stem from stipulations issued by databases and digital archives in which our journal is indexed.

We accept up to 10 figures (2 figures in Research letters). Overtly complex figures will be divided into smaller ones and the number of figures will be counted again. A single figure can have no more than 6 panels (A–F). One panel means one chart – multiple small charts cannot form one panel.

All elements of each figure must be legible when viewed on an A4 page in a PDF file in full-screen mode, without zooming. Overtly complex figures with multiple charts/graphs combined into one panel cannot fulfill this requirement. Figures of low quality cannot be published, and consequently, papers with low-quality figures will not be published, even if accepted by peer reviewers.

Figures should be placed in separate files, not pasted into the main body of the text. Name your figure files with "Fig" and the figure number, e.g., Fig.1.tiff.

References to Figures should be placed according to the sequence of citing them in the manuscript. The text should include references to all figures.

Each figure should have a concise, self-explanatory caption describing accurately what the figure depicts. Captions for the figures should be placed at the end of the main body of the text. Do not embed the legend in the figure file. When applicable, be sure that both the figure captions and the figures themselves contain corresponding labels for multiple parts. Identify all elements found in the figure in the figure caption; and use boxes, circles, etc., as coordinate points in graphs. If any magnification is used in the photographs, indicate this by using scale bars within the figures themselves. All abbreviations used in a given table/figure should be explained below it or in the caption, even if a given abbreviation has already been explained in the text.

If Authors used in the work any figures, photographs, charts, tables, etc. which are not their work, and are protected by the copyright law, they shall be obliged to provide the Publisher with a written authorization to use such materials issued by the author’s economic rights holders. Identify previously published material by giving the original source in the form of a reference citation at the end of the figure caption.

OUR NEW TECHNICAL REQUIREMENTS:

https://advances.umw.edu.pl/source/Adv%20Clin%20Exp%20Med-figures-technical%20requirements.pdf

Adres

Karola Marcinkowskiego 2-6
Wroclaw
50-368

Godziny Otwarcia

Poniedziałek 08:00 - 16:00
Wtorek 08:00 - 16:00
Środa 08:00 - 16:00
Czwartek 08:00 - 16:00
Piątek 08:00 - 16:00

Telefon

+48607983232

Ostrzeżenia

Bądź na bieżąco i daj nam wysłać e-mail, gdy Advances in Clinical and Experimental Medicine umieści wiadomości i promocje. Twój adres e-mail nie zostanie wykorzystany do żadnego innego celu i możesz zrezygnować z subskrypcji w dowolnym momencie.

Skontaktuj Się Z Firmę

Wyślij wiadomość do Advances in Clinical and Experimental Medicine:

Udostępnij

Kategoria